L
Lyell Immunopharma, Inc.
LYEL · NASDAQ · Healthcare · 342M
Price · close
$15.53
+1.17% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.1×
Enterprise value / EBITDAEV/EBITDA
-1.0×
Free cash flow yieldFCF yield
-56.8%
Return on equityROE
-110.6%
Operating margin
-566038.9%
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.